Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2020-11-02 | Steven Salamon was appointed as a director of the Company in May 2020. The current members of the Audit Committee are Elizabeth Czerepak (Chair), Steven Salamon and Roger G. Stoll. The current members of the Nominating Committee are Steven Salamon (Chair), Roger G. Stoll and John Sylvester. |
| 2021-04-07 | The current members of the Audit Committee are Ms. Czerepak (Chair), Mr. Salamon and Dr. Stoll. The Board has determined that each of Ms. Czerepak, Mr. Salamon and Dr. Stoll qualifies as an "audit committee financial expert" as defined by SEC rules. During 2020, the Audit Committee met four times. Each member of the Audit Committee is "independent" within the meaning of the NASDAQ listing rules and otherwise meets the financial statement proficiency requirements of the NASDAQ listing rules. The Audit Committee has a written charter, which is available on our website; go to www.delcath.com, click on "Investors," then "Corporate Governance." The current members of the Nominating Committee are Mr. Salamon (Chair), Dr. Stoll and Mr. Sylvester, each of whom is "independent," within the meaning of the NASDAQ listing rules. During 2020, the Nominating Committee met one time. The following table sets forth the compensation awarded to, earned by or paid to each non-employee director who served on our Board of Directors in 2020. Steven Salamon Fees Earned or Paid in Cash: $37,110 Option Awards: $226,500 Total: $263,610. |
| 2022-04-04 | Steven Salamon was appointed as a director of the Company in May 2020. Mr. Salamon is a co-founder of and has served as Portfolio Manager at Rosalind Advisors, since 2006. |
| 2023-05-01 | Steven Salamon was appointed as a director of the Company in May 2020. The current members of the Audit Committee are Ms. Czerepak (Chair), Mr. Salamon and Dr. Stoll. The current members of the Nominating Committee are Mr. Salamon (Chair), Dr. Stoll and Mr. Sylvester. The following table sets forth the compensation awarded to, earned by or paid to each non-employee director who served on our Board in 2022. Steven Salamon Fees Earned or Paid in Cash ($) 59,000 Option Awards($) 54,121 Total ($) 113,121. |
| 2024-04-12 | Steven Salamon was appointed as a director of the Company in May 2020. Mr. Salamon is a co-founder of, and has served as Portfolio Manager at, Rosalind Advisors, Inc., a life sciences-focused investment manager (“Rosalind Advisors”), since 2006. ... The current members of the Audit Committee are Ms. Czerepak (Chair), Mr. Salamon and Dr. Stoll. ... The current members of the Nominating Committee are Mr. Salamon (Chair), Dr. Stoll and Mr. Sylvester, each of whom is “independent,” within the meaning of the Nasdaq listing rules. ... The following table sets forth the compensation awarded to, earned by or paid to each non-employee director who served on our Board in 2023. ... Steven Salamon 59,000 124,956 183,956 |
| 2025-04-01 | Steven Salamon was appointed as a director of the Company in May 2020. Mr. Salamon is a co-founder of, and has served as Portfolio Manager at, Rosalind Advisors, Inc., a life sciences-focused investment manager (“Rosalind Advisors”), since 2006. The current members of the Audit Committee are Ms. Czerepak (Chair), Mr. Salamon and Dr. Martell. The current members of the Nominating Committee are Mr. Salamon (Chair), Dr. Martell and Mr. Sylvester, each of whom is “independent,” within the meaning of the Nasdaq listing rules. |
Data sourced from SEC filings. Last updated: 2026-02-03